Kidney function decline in working-age adults with cancer diagnosis: A study utilizing claims and health checkup data

Read full text Summarise with VIRAT
Authors: Hiroyuki Watanabe, Masayuki Tsujimoto, Hiroshi Okada, Yoshitaka Hashimoto, Ryo Inose, Michiaki Fukui, Yuichi Muraki
Cited by: 0
References: 29

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Purpose Cancer survivors have an elevated risk of chronic kidney disease (CKD); however, long-term alterations in kidney function among working-age individuals remain underexplored. This study aimed to evaluate differences in the rate of kidney function decline between working-age cancer survivors who received anticancer drug treatment and non-cancer survivors. Methods This retrospective cohort study used data from the Panasonic Health Insurance Organization (2017–2021). The cancer person (CP) and non-cancer person (NCP) groups were defined based on cancer diagnosis and anticancer drug treatment, respectively. Propensity score matching aligned demographics and health factors. Standardized and individualized eGFR changes from the year before diagnosis (Year F) to F + 4 were evaluated across age groups (≤ 50 and ≥ 51 years). Results Each group comprised 395 matched individuals. The CP group demonstrated significant decreases in both standardized and individualized eGFR by F + 4 ( p = 0.007 and p < 0.001, respectively), whereas the NCP group showed no significant decline. The decline was particularly significant in CP ≤ 50 years ( p < 0.001) but not in those ≥ 51 years. Linear mixed-effects models confirmed a significantly larger annual decline in individualized eGFR in the CP group, particularly among younger individuals. Conclusions Working-age cancer survivors, particularly those aged ≤ 50 years, face a significantly higher risk of impaired kidney function than non-cancer survivors. These findings highlight the need for long-term kidney monitoring and protective strategies, especially among younger cancer survivors, to mitigate CKD progression and preserve quality of life and employment outcomes.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Chemotherapy-induced organ toxicity mitigation Cancer survivorship and care

Publication details

Journal / source
Supportive Care in Cancer
Volume
34
Issue
4
Publication date
27 March 2026
Language
EN